Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Werewolf Therapeutics, Inc. | Director | Common Stock | 14.4K | $31.9K | $2.21 | Jan 4, 2024 | Direct |
Werewolf Therapeutics, Inc. | Director | Stock Option (right to buy) | 6.72K | May 24, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HOWL | Werewolf Therapeutics, Inc. | May 24, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
HOWL | Werewolf Therapeutics, Inc. | Jan 4, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
HOWL | Werewolf Therapeutics, Inc. | Jan 4, 2024 | 0 | $0 | 3 | Jan 4, 2024 | Director |